A detailed history of Forum Financial Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Forum Financial Management, LP holds 18,658 shares of GILD stock, worth $1.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,658
Previous 18,634 0.13%
Holding current value
$1.65 Million
Previous $1.28 Million 22.3%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$66.59 - $83.99 $1,598 - $2,015
24 Added 0.13%
18,658 $1.56 Million
Q2 2024

Jul 30, 2024

BUY
$63.15 - $72.88 $268,955 - $310,395
4,259 Added 29.63%
18,634 $1.28 Million
Q1 2024

May 09, 2024

SELL
$71.58 - $87.29 $100,283 - $122,293
-1,401 Reduced 8.88%
14,375 $1.05 Million
Q4 2023

Feb 07, 2024

BUY
$73.27 - $83.09 $14,360 - $16,285
196 Added 1.26%
15,776 $1.28 Million
Q3 2023

Nov 03, 2023

BUY
$73.94 - $80.67 $5,619 - $6,130
76 Added 0.49%
15,580 $1.17 Million
Q2 2023

Jul 26, 2023

BUY
$76.01 - $86.7 $689,790 - $786,802
9,075 Added 141.16%
15,504 $1.19 Million
Q1 2023

Apr 19, 2023

BUY
$77.31 - $88.08 $6,184 - $7,046
80 Added 1.26%
6,429 $533,000
Q4 2022

Jan 24, 2023

SELL
$62.32 - $89.47 $4,113 - $5,905
-66 Reduced 1.03%
6,349 $0
Q3 2022

Nov 07, 2022

SELL
$59.54 - $68.01 $833 - $952
-14 Reduced 0.22%
6,415 $396,000
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $266,608 - $300,281
-4,619 Reduced 41.81%
6,429 $397,000
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $2,085 - $2,612
-36 Reduced 0.32%
11,048 $656,000
Q4 2021

Feb 18, 2022

BUY
$64.88 - $73.64 $719,129 - $816,225
11,084 New
11,084 $805,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $111B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Forum Financial Management, LP Portfolio

Follow Forum Financial Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forum Financial Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Forum Financial Management, LP with notifications on news.